In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zhong, Jia ^a   Sakaki, Masashi ^b   Okada, Hideho ^b   Ahrens, Eric T ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE; FLUOROCARBON; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL LABELING; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXIC T LYMPHOCYTE; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GLIOMA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN TENSION; TUMOR CELL;

ANIMALS; BRAIN NEOPLASMS; FLOW CYTOMETRY; FLUORINE; FLUOROCARBONS; GLIOMA; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MICE; OXYGEN; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84877273676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059479     Document Type: Article

References (45)

1. Wen PY, Kesari S, (2008) Malignant gliomas in adults. New Engl L Med 359: 492-507.
2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466.
3. Holladay FP, Heitz T, Chen YL, Chiga M, Wood GW, (1992) Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes. Neurosurgery 31: 528-533.
4. Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, et al. (2001) Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 61: 842-847.
5. Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M, (2003) Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production. Int J Oncol 23: 483-488.
6. Maes W, Rosas GG, Verbinnen B, Boon L, De Vleeschouwer S, et al. (2009) DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma. Neuro-Oncology 11: 529-542.
7. Okada H, Kohanbash G, Zhu X, Kastenhuber ER, Hoji A, et al. (2009) Immunotherapeutic approaches for glioma. Crit Rev Immunol 29: 1-42.
8. Nishimura F, Dusak JE, Eguchi J, Zhu XM, Gambotto A, et al. (2006) Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: Critical roles of IFN-inducible protein-10. Cancer Res 66: 4478-4487.
9. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, et al. (2006) Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 82: 699-757.
10. Brown JM, Wilson WR, (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437-447.
11. Teicher BA, (1995) Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Hematol Oncol 9: 475-506.
12. Vaupel P, Thews O, Hoeckel M, (2001) Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18: 243-259.
13. Ahrens ET, Flores R, Xu H, Morel PA, (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 23: 983-987.
14. Dardzinski BJ, Sotak CH, (1994) Rapid tissue oxygen tension mapping using 19F inversion-recovery echo- planar imaging of perfluoro-15-crown-5-ether. Magn Reson Med 32: 88-97.
15. Duong TQ, Iadecola C, Kim SG, (2001) Effect of hyperoxia, hypercapnia, and hypoxia on cerebral interstitial oxygen tension and cerebral blood flow. Magn Rreson Med 45: 61-70.
16. Hees PS, Sotak CH, (1993) Assessment of changes in murine tumor oxygenation in response to nicotinamide using 19F NMR relaxometry of a perfluorocarbon emulsion. Magn Reson Med 29: 303-310.
17. Mason RP, Antich PP, Babcock EE, Constantinescu A, Peschke P, et al. (1994) Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol 29: 95-103.
18. van der Sanden BP, Heerschap A, Simonetti AW, Rijken PF, Peters HP, et al. (1999) Characterization and validation of noninvasive oxygen tension measurements in human glioma xenografts by 19F-MR relaxometry. Int J Radiat Oncol 44: 649-658.
19. Zhao D, Jiang L, Mason RP, (2004) Measuring changes in tumor oxygenation. Meth Enzymol 386: 378-418.
20. Guo Q, Mattrey RF, Guclu C, Buxton RB, Nalcioglu O, (1994) Monitoring of pO2 by spin-spin relaxation rate 1/T2 of 19F in a rabbit abscess model. Artif Cells Blood Substit Immobil Biotechnol 22: 1449-1454.
21. Yu JX, Kodibagkar VD, Cui WN, Mason RP, (2005) F-19: A versatile reporter for non-invasive physiology and pharmacology using magnetic resonance. Curr Med Chem 12: 819-848.
22. Mason RP, Shukla H, Antich PP, (1993) In vivo oxygen tension and temperature: simultaneous determination using 19F NMR spectroscopy of perfluorocarbon. Magn Reson Med 29: 296-302.
23. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, et al. (2003) Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 198: 569-580.
24. Prins RM, Odesa SK, Liau LM, (2003) Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model. Cancer Res 63: 8487-8491.
25. Kadayakkara DK, Janjic JM, Pusateri LK, Young WB, Ahrens ET, (2010) In vivo observation of intracellular oximetry in perfluorocarbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI. Magn Reson Med 64: 1252-1259.
26. Parhaml P, Fung B, (1983) Fluorine 19 relaxation study of perfluoro chemicals as oxygen carriers. J Phys Chem 87: 1928-1931.
27. Fujita M, Zhu X, Ueda R, Sasaki K, Kohanbash G, et al. (2009) Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells-Significant Roles of CXCL10. Cancer Res 69: 1587-1595.
28. Insug O, Ku G, Ertl HC, Blaszczyk-Thurin M, (2002) A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. Anticancer Res 22: 613-621.
29. di Carlo E, de Totero D, Piazza T, Fabbi M, Ferrini S, (2007) Role of IL-21 in immune-regulation and tumor immunotherapy. Cancer Immunol Immun 56: 1323-1334.
30. Nastala CL, Edington HD, Mckinney TG, Tahara H, Nalesnik MA, et al. (1994) Recombinant Il-12 Administration Induces Tumor-Regression in Association with Ifn-Gamma Production. J Immunol 153: 1697-1706.
31. Kalinski P, Okada H, (2010) Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors. Semin Immunol 22: 173-182.
32. Okada H, Kalinski P, Ueda R, Hoji A, Kohanbash G, et al. (2011) Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma. J Clin Oncol 29: 330-336.
33. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME, (2008) Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299-308.
34. Zhu X, Nishimura F, Sasaki K, Fujita M, Dusak JE, et al. (2007) Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med 5: 10.
35. Perret R, Ronchese F, (2008) Memory T cells in cancer immunotherapy: which CD8 T-cell population provides the best protection against tumours? Tissue antigens 72: 187-194.
36. El Andaloussi A, Han Y, Lesniak MS, (2006) Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors. J Neurosurg 105: 430-437.
37. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, et al. (2002) Molecular Biology of the Cell Taylor & Francis, Inc.
38. Matsumoto S, Hyodo F, Subramanian S, Devasahayam N, Munasinghe J, et al. (2008) Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice. J Clin Invest 118: 1965-1973.
39. Baldwin NJ, Ng TC, (1996) Oxygenation and metabolic status of KHT tumors as measured simultaneously by F-19 magnetic resonance imaging and P-31 magnetic resonance spectroscopy. Magn Reson Imaging 14: 541-551.
40. Hou HA, Grinberg OY, Taie S, Leichtweis S, Miyake M, et al. (2003) Electron paramagnetic resonance assessment of brain tissue oxygen tension in anesthetized rats. Anesth Analg 96: 1467-1472.
41. Xia M, Kodibagkar V, Liu H, Mason RP, (2006) Tumour oxygen dynamics measured simultaneously by near-infrared spectroscopy and 19F magnetic resonance imaging in rats. Phys Med Biol 51: 45-60.
42. Zhao D, Jiang L, Hahn EW, Mason RP, (2009) Comparison of 1H blood oxygen level-dependent (BOLD) and 19F MRI to investigate tumor oxygenation. Magn Reson Med 62: 357-364.
43. Laukemper-Ostendorf S, Scholz A, Burger K, Heussel CP, Schmittner M, et al. (2002) 19F-MRI of perflubron for measurement of oxygen partial pressure in porcine lungs during partial liquid ventilation. Magn Reson Med 47: 82-89.
44. Lyng H, Sundfor K, Rofstad EK, (1997) Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother Oncol 44: 163-169.
45. Krohn KA, Link JM, Mason RP, (2008) Molecular imaging of hypoxia. J Nucl Med 49: 129S-148S.